Holen Sie sich die Stockscreener-App
3.67
2.65%
-0.10
Handel nachbörslich:
3.67
Schlusskurs vom Vortag:
$3.77
Offen:
$3.69
24-Stunden-Volumen:
258.13K
Relative Volume:
0.42
Marktkapitalisierung:
$232.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.08M
KGV:
-5.0274
EPS:
-0.73
Netto-Cashflow:
$-33.68M
1W Leistung:
-2.65%
1M Leistung:
+46.22%
6M Leistung:
+182.31%
1J Leistung:
+63.11%
1-Tages-Spanne:
$3.55
$3.7643
1-Wochen-Bereich:
$3.55
$4.41
52-Wochen-Spanne:
$0.726
$4.41
Galectin Therapeutics Inc Stock (GALT) Company Profile
Firmenname
Galectin Therapeutics Inc
Sektor
Branche
Telefon
678-620-3186
Adresse
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Vergleichen Sie GALT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
3.67 | 238.61M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-13 | Eingeleitet | B. Riley FBR | Buy |
| 2017-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-19 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Herabstufung | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Herabstufung | ROTH Capital | Buy → Sell |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-09-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-08-01 | Herabstufung | Aegis Capital | Buy → Hold |
| 2014-07-30 | Bestätigt | MLV & Co | Buy |
| 2014-07-29 | Bestätigt | MLV & Co | Buy |
| 2014-04-02 | Bestätigt | MLV & Co | Buy |
| 2014-02-10 | Bestätigt | Aegis Capital | Buy |
| 2014-01-09 | Bestätigt | Aegis Capital | Buy |
| 2013-12-03 | Eingeleitet | MLV & Co | Buy |
| 2013-08-19 | Bestätigt | Aegis Capital | Buy |
Alle ansehen
Galectin Therapeutics Inc Aktie (GALT) Neueste Nachrichten
What recovery options are there for Galectin Therapeutics Inc.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Will Galectin Therapeutics Inc. stock recover after recent dropIPO Watch & Weekly Top Stock Performers List - Newser
What data driven models say about Galectin Therapeutics Inc.’s futureProfit Target & Low Risk Entry Point Guides - Newser
Quantitative breakdown of Galectin Therapeutics Inc. recent movePortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
How institutional ownership impacts Galectin Therapeutics Inc. stockEarnings Beat & Stepwise Trade Signal Implementation - Newser
Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockAI Powered Buy Point Forecast Planner - Newser
Earnings visualization tools for Galectin Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Predicting Galectin Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser
Galectin Therapeutics Inc. stock trend outlook and recovery pathLow Drawdown Picks with Weekly Updates - Newser
Signal strength of Galectin Therapeutics Inc. stock in tech scannersFree Fast Entry High Potential Stock Alerts - Newser
What the charts say about Galectin Therapeutics Inc. todayRisk/Reward Optimization Entry Point Analysis - Newser
How Galectin Therapeutics Inc. stock performs during market volatilityDaily Swing Candidate Analysis with Chart Patterns - Newser
Does Galectin Therapeutics Inc. show high probability of reboundFree Buy Signal Based on Chart Analysis - Newser
Galectin Therapeutics (GALT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Galectin GALT 2025Q2 Earnings Preview Upside Potential on Immunotherapy Advancements - AInvest
Combining price and volume data for Galectin Therapeutics Inc.Downside Risk Evaluation and Stock Analysis - Newser
Galectin Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Strategies to average down on Galectin Therapeutics Inc.Smart Entry Watchlist with Daily Analysis - Newser
Published on: 2025-08-07 02:32:09 - Newser
Is it time to cut losses on Galectin Therapeutics Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Galectin Therapeutics Inc. stock price move sharplyFree Capital Protection Trading Strategies - Newser
Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):